Trials / Completed
CompletedNCT04822350
A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
AVENANCE - A Non-interventional Study to Provide Real-world Data on the Use of Avelumab as a Maintenance Treatment for Patients With Advanced or Metastatic Urothelial Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 596 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter ambispective (retrospective and prospective) non-interventional study of patients with locally advanced or metastatic urothelial carcinoma (adv/mUC) treated with avelumab in France, not impacting the treatment decision made by the treating physician and the medical management of treated patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Avelumab | As provided in real world practice |
Timeline
- Start date
- 2021-07-13
- Primary completion
- 2024-04-25
- Completion
- 2024-04-25
- First posted
- 2021-03-30
- Last updated
- 2026-04-02
- Results posted
- 2026-04-02
Locations
81 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04822350. Inclusion in this directory is not an endorsement.